ClinicalTrials.gg
RecruitingNCT02683473BabyEE PilotUpdated Aug 10, 2026

Measurement of Energy Metabolism in Infants

An observational study in Infant Development and Infant Overnutrition, sponsored by Pennington Biomedical Research Center. Recruiting at 1 site in United States. Open to participants aged 1 Month to 3 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-10.

Sponsored by Pennington Biomedical Research Center · Observational

From the registry’s dates

  • Started Mar 2016; still recruiting 10 years 7 months later.
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
70
Ages
1 Month to 3 Months
Sex
All
01

Study summary

The purpose of this study is to measure energy expenditure during the first 3 months of life in infants.

Read the detailed description

This study intends to establish the feasibility of undertaking comprehensive metabolic phenotyping in infants. The overarching aim is to complete a prospective assessment of energy expenditure in the new infant metabolic chamber approximately one week apart to determine the accuracy and precision of infant protocols related to energy metabolism (sleeping metabolic rate, resting metabolic rate, diet-induced thermogenesis) and physical activity. This cross-sectional study will answer the following questions:

  1. What is the test re-test reliability of measuring energy expenditure (sleeping metabolic rate, resting metabolic rate, diet-induced thermogenesis) in an infant under the same conditions, 5-7 days apart?
  2. What is the reliability of 24h energy expenditure estimated by the infant metabolic chamber in comparison to a 7-day doubly labeled water study?
  3. How do energy expenditure measurements in infants need to be adjusted to account for variability in infant size and body composition?
02

Conditions studied

  • Infant Development
  • Infant Overnutrition
03

In context

Infant Nutrition Disorders

67 studies on the registry are indexed under Infant Nutrition Disorders; 14 are open to participants now.

This study's planned enrollment of 70 is below the median of 203 across 20 observational studies indexed under Infant Nutrition Disorders.

Browse Infant Nutrition Disorders studies →

Lead sponsor

Pennington Biomedical Research Center is the lead sponsor of 284 studies on the registry; 31 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Month to 3 Months
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Full-term infants aged 1 to 3 months who are exclusively fed breast milk and/or infant formula will be recruited

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy, full-term infant
  • Aged 1 month (28 days) to 3 months (12 weeks, 6 days) at the first visit
  • Exclusively fed breast milk and/or infant formula
  • Willing to accept doubly-labeled water

Exclusion criteria

Exclusion Criteria:

  • Unable to complete 3 clinic visits within about 14 days at Pennington Biomedical Research Center
  • Born preterm (\< 37 weeks gestation)
  • Congenital abnormality or disability
  • Gastric reflux
  • Acute illness within 7 days of the study (fever, diarrhea)
  • Use of medications to treat a chronic condition (does not include use of vitamin supplements or PRN medication for flatulence or reflux such as Pepcid)
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
70 participants (estimated)
Patient registry
No

Groups and cohorts

  • Infants

    Infants aged 1-3 months

06

What researchers measure

Primary outcomes

  1. Energy Expenditure by infant metabolic chamber

    Energy expenditure by infant metabolic chamber measured twice about 1 week apart for test re-test reliability in infants aged 1-3 months.

    Time frame: Approximately 1 week

  2. Energy expenditure by doubly labeled water

    Energy expenditure by doubly labeled water measured over approximately 7 days in infants aged 1-3 months

    Time frame: Approximately 1 week

Secondary outcomes

  1. Percent body fat

    Percent body fat by PEA POD measured twice about 1 week apart for test re-test reliability in infants aged 1-3 months.

    Time frame: Approximately 1 week

  2. Physical activity counts

    Physical activity counts by Actigraph accelerometer measured over approximately 7 days in infants aged 1-3 months.

    Time frame: Approximately 1 week

07

Study locations

1 of 1 sites recruiting
  • Pennington Biomedical Research Center
    Baton Rouge, Louisiana 70808, United States
    Recruiting
    • Abby Altazan, M.S. · Contactabby.altazan@pbrc.edu · (225) 763-2801
    • Leanne M Redman, Ph.D. · Principal investigator
    • Eric Ravussin, Ph.D. · Sub investigator
    • Abby Duhé Altazan, M.S. · Sub investigator
    • Daniel Hsia, M.D. · Sub investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02683473
Responsible party
Leanne Redman (Principal Investigator, Pennington Biomedical Research Center) — Principal investigator
First posted
Feb 17, 2016
Start date
Mar 16, 2016
Primary completion
Jun 30, 2027 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
Aug 10, 2026

Study contacts

Abby Altazan, M.S.
Contact
abby.altazan@pbrc.edu
(225) 763-2801
Leanne M Redman, Ph.D.
principal investigator · Pennington Biomedical Research Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion